Bridgeway Capital Management’s Clearside Biomedical CLSD Stock Holding History

Bridgeway Capital Management’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$164K	Sell	205,000 -50,000	-20%	-$40K	﹤0.01%	999
2025 Q1	$234K	Hold	255,000	–	–	0.01%	890
2024 Q4	$242K	Hold	255,000	–	–	0.01%	965
2024 Q3	$324K	Buy	255,000 +125,000	+96%	+$159K	0.01%	963
2024 Q2	$169K	Sell	130,000 -200	-0.2%	-$260	﹤0.01%	1083
2024 Q1	$199K	Sell	130,200 -45,400	-26%	-$69.5K	﹤0.01%	1110
2023 Q4	$205K	Hold	175,600	–	–	﹤0.01%	1131
2023 Q3	$153K	Sell	175,600 -104,000	-37%	-$90.5K	﹤0.01%	1145
2023 Q2	$313K	Sell	279,600 -12,000	-4%	-$13.4K	0.01%	1035
2023 Q1	$303K	Sell	291,600 -25,000	-8%	-$26K	0.01%	1005
2022 Q4	$355K	Hold	316,600	–	–	0.01%	958
2022 Q3	$358K	Hold	316,600	–	–	0.01%	982
2022 Q2	$465K	Hold	316,600	–	–	0.01%	895
2022 Q1	$725K	Hold	316,600	–	–	0.01%	856
2021 Q4	$871K	Hold	316,600	–	–	0.02%	816
2021 Q3	$1.9M	Hold	316,600	–	–	0.04%	638
2021 Q2	$1.54M	Buy	316,600 +40,000	+14%	+$195K	0.03%	718
2021 Q1	$683K	Buy	276,600 +92,600	+50%	+$229K	0.01%	1005
2020 Q4	$504K	Hold	184,000	–	–	0.01%	953
2020 Q3	$283K	Hold	184,000	–	–	0.01%	1093
2020 Q2	$346K	Buy	184,000 +94,000	+104%	+$177K	0.01%	986
2020 Q1	$153K	Hold	90,000	–	–	﹤0.01%	1122
2019 Q4	$261K	Hold	90,000	–	–	﹤0.01%	1151
2019 Q3	$57K	Hold	90,000	–	–	﹤0.01%	1269
2019 Q2	$87K	Hold	90,000	–	–	﹤0.01%	1254
2019 Q1	$124K	Sell	90,000 -49,200	-35%	-$67.8K	﹤0.01%	1264
2018 Q4	$149K	Hold	139,200	–	–	﹤0.01%	1256
2018 Q3	$856K	Buy	139,200 +65,000	+88%	+$400K	0.01%	952
2018 Q2	$793K	Sell	74,200 -37,900	-34%	-$405K	0.01%	966
2018 Q1	$1.2M	Hold	112,100	–	–	0.01%	786
2017 Q4	$785K	Hold	112,100	–	–	0.01%	937
2017 Q3	$980K	Hold	112,100	–	–	0.01%	850
2017 Q2	$1.02M	Buy	112,100 +62,100	+124%	+$566K	0.01%	818
2017 Q1	$397K	Buy	+50,000	New	+$397K	﹤0.01%	1131